Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Background Non‐alcoholic fatty liver disease (NAFLD) represents a significant health threat
worldwide. The growing trend towards an aging population, along with an alarming rise in …

Liver allograft steatosis is a significant risk factor for postoperative graft dysfunction and has
been associated with inferior patient and graft survival, particularly in the case of moderate …

Background Liver disease is a major cause of mortality and morbidity worldwide and its
epidemiology depends on the genetic background, exposure to risk factors, access to …

Lifestyle transformation during the past decades has had a large impact in the increasing
incidence of noncommunicable disease. Since 1990, there has been a marked shift toward …

Liver disease poses a substantial burden in Latin America. This burden is primarily
attributed to a high level of alcohol consumption and the increasing prevalence of risk …

Background Acute-on-chronic liver failure (ACLF) is a severe clinical entity associated with
elevated short-term mortality. We aimed to characterize patients with decompensated …

Liver transplantation (LT) is the only definitive treatment for end-stage liver disease, yet the
UK has seen a 400% increase in liver disease-related deaths since 1970, constrained …

Abstract Metabolic Dysfunction-Associated Fatty Liver Disease and Diabetes Mellitus are
two prevalent metabolic disorders that often coexist and synergistically contribute to the …